Company Filing History:
Years Active: 2018
Title: Ondrej Kotland: Innovator in Hyaluronic Acid Conjugates
Introduction
Ondrej Kotland is a notable inventor based in Predmerice nad Labem, Czech Republic. He has made significant contributions to the field of biochemistry, particularly in the development of innovative conjugates of hyaluronic acid. His work has implications for cancer treatment, showcasing the potential of his inventions in medical applications.
Latest Patents
Kotland holds a patent for "Conjugates of oligomer of hyaluronic acid or of a salt thereof, method of preparation thereof and use thereof." This invention relates to conjugates of hyaluronic acid oligomer, which are designed to enhance biological activity against selected lines of cancer cells. The conjugates are bonded to a substrate through a bi-functional amino linker, allowing for the release of oligomers in their native form. This innovative approach has the potential to improve therapeutic outcomes in cancer treatment.
Career Highlights
Kotland is associated with Contipro A.S., a company known for its advancements in biopolymer research and development. His work at Contipro A.S. has allowed him to focus on the practical applications of his inventions, contributing to the company's reputation as a leader in the field.
Collaborations
He collaborates with talented professionals such as Radovan Buffa and Ivana Basarabova, who share his commitment to advancing research in biochemistry and related fields.
Conclusion
Ondrej Kotland's innovative work in the field of hyaluronic acid conjugates represents a significant advancement in cancer treatment research. His contributions continue to inspire further developments in biochemistry and medicine.